SCRIBE THERAPEUTICS
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR. The company’s first technology, called X-Editing (XE) molecules, are highly engineered CRISPR enzymes that provide combined aspects of greater efficacy, specificity, and deliverability than currently available CRISPR genome editing technology. It also a long-term, engineering approach that can help establish CRISPR-based therapies as a new standard of clinical care and expand access to ground... breaking treatments that will impact millions of lives. Scribe Therapeutics is overcoming the limitations of current genome editing technologies by developing custom-engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company built for exceptional specificity within the genome – enabling therapeutic precision and allele-specific targeting. Scribe Therapeutics was founded in 2018 and is headquartered in Alameda, CA, USA.
SCRIBE THERAPEUTICS
Industry:
Biotechnology Life Science Therapeutics
Founded:
2017-01-01
Address:
Alameda, California, United States
Country:
United States
Website Url:
http://www.scribetx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
120 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Nginx Google Apps For Business
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Wellington Management
Wellington Management investment in Series B - Scribe Therapeutics
T. Rowe Price
T. Rowe Price investment in Series B - Scribe Therapeutics
Avoro Ventures
Avoro Ventures investment in Series B - Scribe Therapeutics
Andreessen Horowitz
Andreessen Horowitz investment in Series B - Scribe Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series B - Scribe Therapeutics
OrbiMed
OrbiMed investment in Series B - Scribe Therapeutics
RA Capital Management
RA Capital Management investment in Series B - Scribe Therapeutics
Avoro Capital Advisors
Avoro Capital Advisors investment in Series B - Scribe Therapeutics
Menlo Ventures
Menlo Ventures investment in Series B - Scribe Therapeutics
Andreessen Horowitz
Andreessen Horowitz investment in Series A - Scribe Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-09 | Scribe Therapeutics Appoints David Parrot as Chief Financial Officer and George Manning as Controller |
Official Site Inspections
http://www.scribetx.com
- Host name: 152.238.196.35.bc.googleusercontent.com
- IP address: 35.196.238.152
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
